G Medical Innovations Holdings Limited - Warrants (30/06/2025) EBIT

As of the most recent data (December 2021), GMVDW shows a EBIT of $6.1M. That compares with $-20M in the prior-year period — up 130.8% year over year. That is below the Healthcare sector average of $23B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GMVDW's EBIT is now $6.1M (was $-20M) — a 130.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether G Medical Innovations Holdings Limited - Warrants (30/06/2025) is outperforming or lagging.

The Healthcare sector average EBIT is about $23B. G Medical Innovations Holdings Limited - Warrants (30/06/2025) is at $6.1M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how GMVDW stacks up against individual peers as well.

Tracking GMVDW's ebit over time shows whether G Medical Innovations Holdings Limited - Warrants (30/06/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $6.1M That compares with $-20M in the prior-year period — up 130.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has G Medical Innovations Holdings Limited - Warrants (30/06/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $6.1M) with ownership activity and broader fundamentals.